Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clenbuterol - Avenue Therapeutics

Next Previous
Drug Profile

Clenbuterol - Avenue Therapeutics

Alternative Names: ATX-04

Latest Information Update: 15 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Duke University
  • Class Alkanes; Aniline compounds; Antiasthmatics; Antibronchitics; Chlorobenzenes; Ethanolamines; Small molecules
  • Mechanism of Action Beta adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Glycogen storage disease type II
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Glycogen storage disease type II

Most Recent Events

  • 01 Apr 2026 Avenue anticipates meeting with the FDA to discuss and align on the design of a potential single pivotal trial for ATX 04 for Pompe disease in 2026
  • 01 Apr 2026 Chemical structure information added.
  • 30 Mar 2026 Avenue Therapeutics plans a pre-IND meeting with the US FDA for a pivotal study design for Glycogen storage disease type II

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top